Skip to main content
. 2024 Dec 31;69(2):e01448-24. doi: 10.1128/aac.01448-24

Fig 3.

Two graphs display IFN-gamma levels and IgG levels in three groups of sheep over 56 days: T. gondii-infected and treated, G1; infected and untreated, G2; non-infected mice. G1 displays reduced IFN and RIPC levels compared with G2.

IFNγ levels (A) and anti-T. gondii IgG levels (B) in serum. In A, concentrations of IFNγ are expressed in pg/mL. In B, anti-T. gondii IgG levels are expressed in relative index percent (RIPC). Each point represents the mean + SD at the different sampling times for each group. The black arrow points the beginning of the treatment on day 7 p.i. Horizontal dashed lines in B indicate the cut-off (RIPC ≥19.18) for experimental conditions established by the previously validated TgSALUVET ELISA 2.0 (52). For significant differences between infected groups, (*) indicates P < 0.05, (**) indicates P < 0.01, and (****) indicates P < 0.0001.